Cardiosolutions develops the Mitra-Spacer™, a proprietary percutaneous implant designed to fill the void from a dilated valvular annulus and provide a sealing surface for diseased mitral valve leaflets. The company has also developed the Dexterity™ Steerable Introducer System for advancement and delivery of cardiovascular catheters. Its technology targets patients with moderate to severe mitral regurgitation, including many who are high-risk for surgery or currently untreated. Cardiosolutions was incubated within and spun out of STD Med in 2006 and is based in West Bridgewater, Massachusetts. The company is focused on ongoing product development and clinical testing to advance its minimally invasive therapy toward clinical use. Recent financing will support those development and clinical activities and positions the company for potential strategic partnership or exit.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2012